| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMDX | Common Stock | Options Exercise | $54.2K | +1.41K | +9.99% | $38.46 | 15.5K | Jan 17, 2023 | Direct | F1, F7 |
| transaction | TMDX | Common Stock | Sale | -$3.83K | -63 | -0.41% | $60.72 | 15.5K | Jan 17, 2023 | Direct | F1, F2, F7 |
| transaction | TMDX | Common Stock | Sale | -$27.5K | -446 | -2.88% | $61.77 | 15K | Jan 17, 2023 | Direct | F1, F3, F7 |
| transaction | TMDX | Common Stock | Sale | -$21.1K | -338 | -2.25% | $62.48 | 14.7K | Jan 17, 2023 | Direct | F1, F4, F7 |
| transaction | TMDX | Common Stock | Sale | -$28.6K | -449 | -3.06% | $63.70 | 14.2K | Jan 17, 2023 | Direct | F1, F5, F7 |
| transaction | TMDX | Common Stock | Sale | -$7.33K | -114 | -0.8% | $64.30 | 14.1K | Jan 17, 2023 | Direct | F1, F6, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMDX | Stock Option (Right to Buy) | Options Exercise | $0 | -1.41K | -9.4% | $0.00 | 13.6K | Jan 17, 2023 | Common Stock | 1.41K | $38.46 | Direct | F1, F8 |
| Id | Content |
|---|---|
| F1 | The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.12 to $61.07, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.18 to $62.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F4 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.18 to $63.17, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F5 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.19 to $64.18, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F6 | The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $64.19 to $64.52, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F7 | The amount of securities directly owned by the Reporting Person includes 276 shares of common stock acquired under the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan. |
| F8 | The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021. |